lumasiran
General
Pronunciation:
loo-ma-sir-an
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Oxlumo
Ther. Class.
none assigned
Pharm. Class.
hydroxyacid oxidase 1 (HAO1) directed small interfering ribonucleic acid (siRNA)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Lumasiran." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580025/10/lumasiran.
Vallerand AHA, Sanoski CAC. Lumasiran. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580025/10/lumasiran. Accessed June 26, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Lumasiran. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580025/10/lumasiran
Vallerand AHA, Sanoski CAC. Lumasiran [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 26]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580025/10/lumasiran.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - lumasiran
ID - 3580025
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580025/10/lumasiran
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

